BMI View: With restrictions on financial aid into Uganda following the passing of the anti-homosexuality
bill, we believe that improvements in healthcare coverage may start to wane, as the government attempts to
manage a more limited budget. Nevertheless, progress con ..."
BMI View: We do not expect Uganda's reliance on imported drugs to decrease, even though the
government has been encouraging the domestic production of drugs. Additionally, export growth will be
slow due to the limited capabilities of local pharmaceutical companies, which are un ..."
BMI View: The past few years have seen a number of important and encouraging regulatory developments
in East Africa's pharmaceutical sector, which is positive for companies looking to market their products in
the region. The 2012 East African Community (EAC) Medicines ..."
BMI View: Investment into Uganda's pharmaceuticals and healthcare sector by companies to meet the
demand for healthcare services is an advisable business strategy - as highlighted by the high growth
forecast in healthcare spending between 2012 and 2017. However, we note that th ..."
BMI View: Economic growth and the resulting increase in Uganda's middle-class population will lead to
rising demand for quality healthcare services as incomes improve. Investment into private healthcare
facilities in Uganda in order to meet the demand for services is therefore ..."
While geographic diversification and investment into the pharmaceutical and healthcare sector of emerging economies such as Uganda may be a favourable strategy for any multinational pharmaceutical company - it is vital that a company recognises both the rewards and the risks pres ..."
BMI View: While geographic diversification and investment into the pharmaceutical and healthcare
sector of emerging economies such as Uganda may be a favourable strategy for any multinational
pharmaceutical company - it is vital that a company recognises both the rewards and th ..."